Cargando…

Challenges of measuring accurate estradiol levels in aromatase inhibitor‐treated postmenopausal breast cancer patients on vaginal estrogen therapy

Breast cancer patients who are taking adjuvant Aromatase Inhibitor (AI) therapy typically have extremely low estradiol levels, which are undetectable by routine clinical laboratories. Thus, it becomes difficult to assess the safety of interventions such as low‐dose vaginal estrogen, which may increa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niravath, Polly, Bhat, Raksha, Al‐Ameri, Mohamed, AlRawi, Ahmed, Foreman, Claudette, Trivedi, Meghana V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684855/ https://www.ncbi.nlm.nih.gov/pubmed/28805983 http://dx.doi.org/10.1002/prp2.330

Ejemplares similares

Simultaneous Quantification of Aromatase Inhibitors and Estrogens in Postmenopausal Breast Cancer Patients
por: Bertelsen, Bjørn-Erik, et al.
Publicado: (2021)

Systemic estradiol levels with low-dose vaginal estrogens
por: Santen, Richard J., et al.
Publicado: (2019)

Improved compliance and patient satisfaction with estradiol vaginal tablets in postmenopausal women previously treated with another local estrogen therapy
por: Minkin, Mary Jane, et al.
Publicado: (2013)

Association of Vaginal Estradiol Tablet With Serum Estrogen Levels in Women Who Are Postmenopausal: Secondary Analysis of a Randomized Clinical Trial
por: Mitchell, Caroline M., et al.
Publicado: (2022)

Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer
por: Pfeiler, G, et al.
Publicado: (2013)

Vaginal Flora in Postmenopausal Women: The Effect of Estrogen Replacement
por: Ginkel, Paul D., et al.
Publicado: (1993)

Serum estradiol level according to dose and formulation of oral estrogens in postmenopausal women
por: Kim, Soo-Min, et al.
Publicado: (2021)

Postmenopausal vaginal atrophy: evaluation of treatment with local estrogen therapy
por: Minkin, Mary Jane, et al.
Publicado: (2014)

Role of vaginal estradiol pretreatment combined with vaginal misoprostol for cervical ripening before operative hysteroscopy in postmenopausal women
por: Casadei, Luisa, et al.
Publicado: (2016)

Testosterone-derived estradiol production by male endothelium is robust and dependent on p450 aromatase via estrogen receptor alpha
por: Villablanca, Amparo C, et al.
Publicado: (2013)

Deficiencies in immunoassay methods used to monitor serum Estradiol levels during aromatase inhibitor treatment in postmenopausal breast cancer patients
por: Jaque, Jenny, et al.
Publicado: (2013)

Molecular analysis of the vaginal response to estrogens in the ovariectomized rat and postmenopausal woman
por: Jelinsky, Scott A, et al.
Publicado: (2008)

Postmenopausal vaginal atrophy: evaluation of treatment with local estrogen therapy [Erratum]
Publicado: (2014)

Comparison of the effect of licorice vaginal cream and estrogen vaginal cream on sexual function of postmenopausal women: An RCT
por: Ahmadizad, Parisa, et al.
Publicado: (2022)

A comparative study of vaginal estrogen cream and sustained-release estradiol vaginal tablet (Vagifem) in the treatment of atrophic vaginitis in Isfahan, Iran in 2010-2012
por: Hosseinzadeh, Pardis, et al.
Publicado: (2015)

Comparison of the Efficacy of Vaginal Hyaluronic Acid to Estrogen for the Treatment of Vaginal Atrophy in Postmenopausal Women: A Systematic Review
por: Albalawi, Nada Saleh, et al.
Publicado: (2023)

Estrogen Receptor Alpha Polymorphisms, Estradiol Level, and Occurrence of Atherosclerosis Risk Factors in Healthy Postmenopausal Women
por: Bojar, Iwona, et al.
Publicado: (2015)

Cognitive Functions, Concentration of Endogenous Estradiol, Estrogen Receptor α (ERα) Polymorphism in Postmenopausal Women
por: Bojar, Iwona, et al.
Publicado: (2016)

Conjugated equine estrogen used in postmenopausal women associated with a higher risk of stroke than estradiol
por: Chang, Wei-Chuan, et al.
Publicado: (2021)

Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors
por: Donders, G., et al.
Publicado: (2015)

Saudi English: A Descriptive Analysis of English Language Variations in Saudi Arabia
por: AlRawi, Maather, et al.
Publicado: (2022)

Comparison between vaginal royal jelly and vaginal estrogen effects on quality of life and vaginal atrophy in postmenopausal women: a clinical trial study
por: Seyyedi, Fatemeh, et al.
Publicado: (2016)

NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer
por: Bhat, Raksha, et al.
Publicado: (2022)

The Aromatase–Estrogen System in the Testes of Non-Mammalian Vertebrates
por: Rosati, Luigi, et al.
Publicado: (2021)

Chitosan/Solid-Lipid Nanoparticles Hybrid Gels for Vaginal Delivery of Estradiol for Management of Vaginal Menopausal Symptoms
por: Abou-Taleb, Heba A., et al.
Publicado: (2023)

Estrogen receptors α and β and aromatase as independent predictors for prostate cancer outcome
por: Grindstad, Thea, et al.
Publicado: (2016)

Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration: Case Series and Review of Literature
por: Chatham, Mathew, et al.
Publicado: (2021)

Sexual dimorphism of brain aromatase activity in medaka: induction of a female phenotype by estradiol.
por: Melo, A C, et al.
Publicado: (2001)

Aromatase Derived Estradiol Within the Thalamus Modulates Pain Induced by Varicella Zoster Virus
por: Kramer, Phillip R., et al.
Publicado: (2018)

The Utilization and Impact of Aromatase Inhibitor Therapy in Men With Elevated Estradiol Levels on Testosterone Therapy
por: Punjani, Nahid, et al.
Publicado: (2021)

ODP540 Aromatase interacting partner in Breast (AIPB) regulates estradiol in human breast
por: Moffitt, Alyssa M, et al.
Publicado: (2022)

Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor
por: García-Sáenz, José Á., et al.
Publicado: (2022)

Aromatase expression and role of estrogens in male gonad : a review
por: Carreau, Serge, et al.
Publicado: (2003)

A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom
por: Archer, David F., et al.
Publicado: (2018)

Consistency of Effect with a Low-Dose, Estradiol Vaginal Capsule (TX-004HR): Evaluating Improvement in Vaginal Physiology and Moderate-to-Severe Dyspareunia in Subgroups of Postmenopausal Women
por: Constantine, Ginger D., et al.
Publicado: (2017)

Patterns of Expression of Vaginal T-Cell Activation Markers during Estrogen-Maintained Vaginal Candidiasis
por: Al-Sadeq, Ameera, et al.
Publicado: (2008)

Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study
por: Donders, Gilbert, et al.
Publicado: (2014)

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
por: Jayaraman, Swaathi, et al.
Publicado: (2020)

Postmenopausal Vaginal Microbiome and Microbiota
por: de Oliveira, Nayara Santos, et al.
Publicado: (2022)

Interplay between estrogen receptor and AKT in Estradiol-induced alternative splicing
por: Bhat-Nakshatri, Poornima, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_508l5di5dkapmilesbi6odf7gs